Economic evaluation of human papillomavirus vaccination in the United Kingdom. [PDF]
, 2008 OBJECTIVE: To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom. DESIGN: Economic evaluation. SETTING: UK. Population Schoolgirls aged 12 or older.
Choi, Yoon Hong +2 more
core +1 more source
A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections. [PDF]
PLoS ONE, 2015 Papillomavirus disease and associated cancers remain a significant health burden in much of the world. The current protective vaccines, Gardasil and Cervarix, are expensive and not readily available to the underprivileged.
Nancy M Cladel +5 more
doaj +1 more source
Eliminat Cervical Cancer, Focusing on Primary Prevention
Zhongliu Fangzhi Yanjiu, 2023 As one of the most severe malignant tumors, cervical cancer poses a significant threat to women. In 2020, the World Health Organization (WHO) introduced the "Global Strategy to Accelerate the Elimination of Cervical Cancer" in response to well ...
ZHAO Chao, LI Mingzhu, WEI Lihui
doaj +1 more source
Plant production and immunogenic characterisation of Human papillomavirus chimaeric vaccines [PDF]
, 2011 Includes abstract.Includes bibliographical references (leaves 153-175).Cervical cancer is primarily caused by infection with Human papillomavirus (HPV) and is a global concern, particularly in developing countries which contain ~80% of the cervical ...
Pineo, Catherine
core +1 more source
Proceedings of Singapore Healthcare, 2017 Introduction: Although cervical cancer is the 10th most common cancer among females in Singapore, it is a vaccine-preventable cancer. Human papillomavirus vaccines combined with regular Pap (papillomavirus) smears have been shown to reduce the mortality ...
Sarah Woon Ching Lim +9 more
doaj +1 more source
Optimization of multimeric human papillomavirus L2 vaccines. [PDF]
PLoS ONE, 2013 We sought to define the protective epitopes within the amino terminus of human papillomavirus (HPV) type 16 minor capsid protein L2. Passive transfer of mice with rabbit antisera to HPV16 L2 peptides 17-36, 32-51 and 65-81 provided significant protection
Subhashini Jagu +6 more
doaj +1 more source
Human Papillomavirus Vaccines and Vaccine Implementation [PDF]
Women's Health, 2008 Countries are now challenged by the rapid development of vaccines aimined at the primary prevention of infections. In the years to come, several vaccines will need to be considered as potential candidates in routine immunization programs. Recently, two new vaccines against two/four types of human papillomavirus (HPV) have been commercialized. Bivalent
Silvia, de Sanjosé +3 more
openaire +2 more sources
The Efficacy of Therapeutic DNA Vaccines Expressing the Human Papillomavirus E6 and E7 Oncoproteins for Treatment of Cervical Cancer: Systematic Review [PDF]
, 2021 Cervical cancer is recognized as a serious public health problem since it remains one of the most common cancers with a high mortality rate among women despite existing preventative, screening, and treatment approaches.
Ayazhan Akhatova +8 more
core +1 more source
New Perspectives in Therapeutic Vaccines for HPV: A Critical Review
Medicina, 2022 Human Papillomavirus is the main cause of cervical cancer, including squamous cell carcinoma of the oropharynx, anus, rectum, penis, vagina, and vulva.
Barbara Gardella +9 more
doaj +1 more source
E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domai [PDF]
, 2006 Human papillomavirus type 16 E5 protein (HPV-16 E5) is expressed early in papillomavirus infection and is localised primarily in the cell Golgi apparatus (GA) and endoplasmic reticulum. E5 prevents transport of the major histocompatibility class I (MHC I;
Marchetti, Barbara +7 more
core +1 more source